Anticancer drugs from traditional toxic Chinese medicines

Phytotherapy Research

Volumn 26, Issue 10, 2012, Pages 1449-1465

  Man, Shuli ^a   Gao, Wenyuan ^a,b   Wei, Changlong ^a   Liu, Changxiao ^c  

^a TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TIANJIN UNIVERSITY   (China)

^c State Key Laboratories of Pharmacodynamics and Pharmacokinetics   (China)

Author keywords

anticancer; arsenic trioxide; mechanism; phytochemistry; toxic effects; traditional toxic Chinese medicine

Indexed keywords

ABIETANE; ALKALOID DERIVATIVE; ANTINEOPLASTIC AGENT; ARSENIC; ARSENIC DERIVATIVE; ARYLNAPHTHALENE LIGNAN; BISBENZYLTETRAHYDROISOQUINOLINE; CHOLESTANE DERIVATIVE; DAPHNANE; DITERPENOID; HERBACEOUS AGENT; INDOLE DERIVATIVE; INGENANE; KETONE DERIVATIVE; LATHYRANE; LIGNAN DERIVATIVE; MONOTERPENOID; MONOTERPENOID INDOLE; PHENETHYLTETRAHYDROISOQUINOLINE; PHYTOSTEROL; QUNINZOLINE; REALGAR; SESQUITERPENE LACTONE; SESQUITERPENE TRILACTONE; TERPENOID DERIVATIVE; TIGLIANE; TOXIC SUBSTANCE; TRIEPOXIDE; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; BONE MARROW SUPPRESSION; BRUCEA JAVANICA; CAMPTOTHECA ACCUMINATA; CANCER COMBINATION CHEMOTHERAPY; CATHARANTHUS ROSEUS; CEPHALOTAXUS FORTUNEI; CHEMICAL MODIFICATION; CHINESE MEDICINE; CYSTITIS; DAPHNE GENKWA; DIARRHEA; DRUG BIOAVAILABILITY; DRUG MECHANISM; DRUG STRUCTURE; DYSOSMA VERSIPELLIS; EUPHORBIA FISCHERIANA; EUPHORBIA KANSUI; EUPHORBIA LATHYRIS; GARCINIA HANBURYI; GASTROINTESTINAL SYMPTOM; GINKGO BILOBA; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; MEDICINAL PLANT; MELIA TOOSENDAN; MYLABRIS; NAUSEA; NEUROTOXICITY; NONHUMAN; PARIS POLYPHYLLA; PERIPLOCA SEPIUM; PHYTOCHEMISTRY; PODOPHYLLUM EMODI; PSEUDOLARIX KAEMPFERI; RASH; REVIEW; TRIPTERYGIUM WILFORDII; URINARY TRACT DISEASE;

ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUGS, CHINESE HERBAL; HUMANS; KETONES; LIGNANS; MEDICINE, CHINESE TRADITIONAL; NEOPLASMS; PHYTOTHERAPY; PLANTS, MEDICINAL; STEROIDS; TERPENES;

ANIMALIA; BRUCEA JAVANICA; CAMPTOTHECA ACUMINATA; CATHARANTHUS ROSEUS; CEPHALOTAXUS FORTUNEI; DAPHNE GENKWA; DYSOSMA VERSIPELLIS; EUPHORBIA FISCHERIANA; EUPHORBIA KANSUI; EUPHORBIA LATHYRIS; GARCINIA HANBURYI; GINKGO BILOBA; MELIA TOOSENDAN; MYLABRIS; PARIS POLYPHYLLA; PERIPLOCA SEPIUM; PSEUDOLARIX KAEMPFERI; SINOPODOPHYLLUM HEXANDRUM; TRIPTERYGIUM WILFORDII;

EID: 84867334041     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4609     Document Type: Review

References (177)

1. Ahn H, Nam JW, Seo EK, Mar W,. 2008. Induction of NAD(P)H: quinone reductase by rutaecarpine isolated from the fruits of Evodia rutaecarpa in the murine hepatic Hepa-1c1c7 cell line. Planta Med 74: 1387-1390.
2. An WW, Wang MW, Tashiro S, Onodera S, Ikejima T,. 2004. Norcantharidin induces human melanoma A375-S2 cell apoptosis through mitochondrial and caspase pathways. J Korean Med Sci 19: 560-566.
3. Antman KH,. 2001. Introduction: the history of arsenic trioxide in cancer therapy. Oncologist 6 (Suppl 2): 1-2.
4. Appendino G, Della Porta C, Conseil G, et al,. 2003. A new P-glycoprotein inhibitor from the caper spurge (Euphorbia lathyris). J Nat Prod 66: 140-142.
5. Baj G, Arnulfo A, Deaglio S, et al,. 2002. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res Treat 73: 61-73.
6. Basili S, Moro S,. 2009. Novel camptothecin derivatives as topoisomerase I inhibitors. Expert Opin Ther Pat 19: 555-574.
7. Batova A, Altomare D, Chantarasriwong O, et al,. 2010. The synthetic caged garcinia xanthone cluvenone induces cell stress and apoptosis and has immune modulatory activity. Mol Cancer Ther 9: 2869-2878.
8. Beauchamp EM, Ringer L, Bulut G, et al,. 2011. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway. J Clin Invest 121: 148-160.
9. Bloise E, Braca A, De Tommasi N, et al,. 2009. Pro-apoptotic and cytostatic activity of naturally occurring cardenolides. Cancer Chemother Pharmacol 64: 793-802.
10. Cao Y, Song Y, An N, et al,. 2009. The effects of telocinobufagin isolated from Chan Su on the activation and cytokine secretion of immunocytes in vitro. Fundam Clin Pharmacol 23: 457-464.
11. Carter BZ, Mak DH, Schober WD, et al,. 2006. Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells. Blood 108: 630-637.
12. Chan AL, Chang WS, Chen LM, et al,. 2009. Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules 14: 1342-1352.
13. Chan WH, Hsuuw YD,. 2007. Dosage effects of ginkgolide B on ethanol-induced cell death in human hepatoma G2 cells. Ann N Y Acad Sci 1095: 388-398.
14. Chang C, Zhu YQ, Mei JJ, Liu SQ, Luo J,. 2010. Involvement of mitochondrial pathway in NCTD-induced cytotoxicity in human hepG2 cells. J Exp Clin Cancer Res 29: 145.
15. Chen J, Ye Y, Sun C, Pan Y,. 2008. Rapid identification of oleanane-type saponins in the roots of Stephanotis mucronata by liquid chromatography/ electrospray tandem mass spectrometry. Anal Chim Acta 613: 74-82.
16. Chen YJ, Chang WM, Liu YW, et al,. 2009. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells. Chem Biol Interact 181: 440-446.
17. Chen YJ, Shieh CJ, Tsai TH, et al,. 2005. Inhibitory effect of norcantharidin, a derivative compound from blister beetles, on tumor invasion and metastasis in CT26 colorectal adenocarcinoma cells. Anticancer Drugs 16: 293-299.
18. Cheung JY, Ong RC, Suen YK, et al,. 2005. Polyphyllin D is a potent apoptosis inducer in drug-resistant HepG2 cells. Cancer Lett 217: 203-211.
19. Chiu LY, Ko JL, Lee YJ, Yang TY, Tee YT, Sheu GT,. 2010. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. Toxicol Lett 192: 408-418.
20. Choi JS, Kang NS, Min YK, Kim SH,. 2010. Euphorbiasteroid reverses P-glycoprotein-mediated multi-drug resistance in human sarcoma cell line MES-SA/Dx5. Phytother Res 24: 1042-1046.
21. Cuendet M, Pezzuto JM,. 2004. Antitumor activity of bruceantin: an old drug with new promise. J Nat Prod 67: 269-272.
22. Damayanthi Y, Lown JW,. 1998. Podophyllotoxins: current status and recent developments. Curr Med Chem 5: 205-252.
23. 2+ involved mitochondrial pathway. Toxicol Sci 91: 59-69.
24. Deng XK, Yin W, Li WD, et al,. 2006b. The anti-tumor effects of alkaloids from the seeds of Strychnos nux-vomica on HepG2 cells and its possible mechanism. J Ethnopharmacol 106: 179-186.
25. Dorn DC, Kou CA, Png KJ, Moore MA,. 2009. The effect of cantharidins on leukemic stem cells. Int J Cancer 124: 2186-2199.
26. Du YH, Ho PC,. 2001. Arsenic compounds induce cytotoxicity and apoptosis in cisplatin-sensitive and -resistant gynecological cancer cell lines. Cancer Chemother Pharmacol 47: 481-490.
27. Du YY, Liu X, Shan BE,. 2009. Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway. Ai Zheng 28: 456-460.
28. Efferth T, Rauh R, Kahl S, et al,. 2005. Molecular modes of action of cantharidin in tumor cells. Biochem Pharmacol 69: 811-818.
29. Fan YZ, Fu JY, Zhao ZM, Chen CQ,. 2007. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Hepatobiliary Pancreat Dis Int 6: 72-80.
30. Fan YZ, Zhao ZM, Fu JY, Chen CQ,. 2006. Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo. Zhonghua Wai Ke Za Zhi 44: 618-622.
31. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM,. 2010. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917.
32. 3) induced calcium signals and cytotoxicity in two human cell lines: SY-5Y neuroblastoma and 293 embryonic kidney (HEK). Toxicol Appl Pharmacol 220: 292-301.
33. Gordaliza M, Castro MA, del Corral JM, Feliciano AS,. 2000. Antitumor properties of podophyllotoxin and related compounds. Curr Pharm Des 6: 1811-1839.
34. Gowda RM, Cohen RA, Khan IA,. 2003. Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implications. Heart 89: e14.
35. Groth-Pedersen L, Ostenfeld MS, Hoyer-Hansen M, Nylandsted J, Jaattela M,. 2007. Vincristine induces dramatic lysosomal changes and sensitizes cancer cells to lysosome-destabilizing siramesine. Cancer Res 67: 2217-2225.
36. Guo L, Su J, Deng BW, et al,. 2008. Active pharmaceutical ingredients and mechanisms underlying phasic myometrial contractions stimulated with the saponin extract from Paris polyphylla Sm. var. yunnanensis used for abnormal uterine bleeding. Hum Reprod 23: 964-971.
37. Guo QL, Lin SS, You QD, et al,. 2006. Inhibition of human telomerase reverse transcriptase gene expression by gambogic acid in human hepatoma SMMC-7721 cells. Life Sci 78: 1238-1245.
38. Hahnvajanawong C, Boonyanugomol W, Nasomyon T, et al,. 2010. Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. World J Gastroenterol 16: 2235-2243.
39. Han QB, Wang YL, Yang L, et al,. 2006a. Cytotoxic polyprenylated xanthones from the resin of Garcinia hanburyi. Chem Pharm Bull(Tokyo) 54: 265-267.
40. Han Q, Yang L, Liu Y, et al,. 2006b. Gambogic acid and epigambogic acid, C-2 epimers with novel anticancer effects from Garcinia hanburyi. Planta Med 72: 281-284.
41. Han QB, Yang L, Wang YL, et al,. 2006c. A pair of novel cytotoxic polyprenylated xanthone epimers from gamboges. Chem Biodivers 3: 101-105.
42. He D, Xu Q, Yan M, et al,. 2009. The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma. BMC Cancer 9: 343.
43. Hong JY, Nam JW, Seo EK, Lee SK,. 2010. Daphnane diterpene esters with anti-proliferative activities against human lung cancer cells from Daphne genkwa. Chem Pharm Bull(Tokyo) 58: 234-237.
44. Huan SK, Lee HH, Liu DZ, Wu CC, Wang CC,. 2006. Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell line. Toxicology 223: 136-143.
45. Huang CF, Yang RS, Liu SH, Hsieh PC, Lin-Shiau SY,. 2011. Evidence for improved neuropharmacological efficacy and decreased neurotoxicity in mice with traditional processing of Rhizoma Arisaematis. Am J Chin Med 39: 981-998.
46. Huh JE, Kang KS, Chae C, Kim HM, Ahn KS, Kim SH,. 2004. Roles of p38 and JNK mitogen-activated protein kinase pathways during cantharidin-induced apoptosis in U937 cells. Biochem Pharmacol 67: 1811-1818.
47. Ji H, Wang FP,. 2006. Structure of lasiansine from Aconitumnagarum var. lasiandrum. J Asian Nat Prod Res 8: 619-624.
48. Jiang XH, Wong BC, Lin MC, et al,. 2001a. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric cancer cells. Oncogene 20: 8009-8018.
49. Jiang XH, Wong BC, Yuen ST, et al,. 2001b. Arsenic trioxide induces apoptosis in human gastric cancer cells through up-regulation of p53 and activation of caspase-3. Int J Cancer 91: 173-179.
50. Jiao W, Dong W, Li Z, Deng M, Lu R,. 2009. Lathyrane diterpenes from Euphorbia lathyris as modulators of multidrug resistance and their crystal structures. Bioorg Med Chem 17: 4786-4792.
51. Jin W, Di G, Li J, et al,. 2007. TIEG1 induces apoptosis through mitochondrial apoptotic pathway and promotes apoptosis induced by homoharringtonine and velcade. FEBS Lett 581: 3826-3832.
52. Jin Y, Chen Q, Shi X, et al,. 2009. Activity of triptolide against human mast cells harboring the kinase domain mutant KIT. Cancer Sci 100: 1335-1343.
53. Jin Y, Lu Z, Cao K, et al,. 2010. The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation. Mol Cancer Ther 9: 211-223.
54. Kang YH, Lee SJ,. 2008. The role of p38 MAPK and JNK in arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. J Cell Physiol 217: 23-33.
55. Kang YH, Yi MJ, Kim MJ, et al,. 2004. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res 64: 8960-8967.
56. Kantarjian HM, Talpaz M, Santini V, Murgo A, Cheson B, O'Brien SM,. 2001. Homoharringtonine: history, current research, and future direction. Cancer 92: 1591-1605.
57. Kiviharju TM, Lecane PS, Sellers RG, Peehl DM,. 2002. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res 8: 2666-2674.
58. Ko JK, Leung WC, Ho WK, Chiu P,. 2007. Herbal diterpenoids induce growth arrest and apoptosis in colon cancer cells with increased expression of the nonsteroidal anti-inflammatory drug-activated gene. Eur J Pharmacol 559: 1-13.
59. Lau ST, Lin ZX, Liao Y, Zhao M, Cheng CH, Leung PS,. 2009. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase. Cancer Lett 281: 42-52.
60. Lee J, Min B, Lee S, et al,. 2002. Cytotoxic sesquiterpene lactones from Carpesium abrotanoides. Planta Med 68: 745-747.
61. Lee JC, Su CL, Chen LL, Won SJ,. 2009. Formosanin C-induced apoptosis requires activation of caspase-2 and change of mitochondrial membrane potential. Cancer Sci 100: 503-513.
62. Lee MS, Yuet-Wa JC, Kong SK, et al,. 2005. Effects of polyphyllin D, a steroidal saponin in Paris polyphylla, in growth inhibition of human breast cancer cells and in xenograft. Cancer Biol Ther 4: 1248-1254.
63. Legarza K, Yang LX,. 2006. New molecular mechanisms of action of camptothecin-type drugs. Anticancer Res 26: 3301-3305.
64. Li B, Ling CQ,. 2002. Advances in basic and clinical studies of norcantharidin. Chin Tradit Herbal Drugs 33: 184-185.
65. Li MH, Miao ZH, Tan WF, et al,. 2004. Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1alpha by promoting proteasome-mediated degradation. Clin Cancer Res 10: 8266-8274.
66. Li Q, Cheng H, Zhu G, et al,. 2010. Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting. Biol Pharm Bull 33: 415-420.
67. Li R, Chen Y, Zeng LL, et al,. 2009. Gambogic acid induces G0/G1 arrest and apoptosis involving inhibition of SRC-3 and inactivation of Akt pathway in K562 leukemia cells. Toxicology 262: 98-105.
68. Li SL, Song JZ, Han QB, Qiao CF, Xu HX,. 2008. Improved high-performance liquid chromatographic method for simultaneous determination of 12 cytotoxic caged xanthones in gamboges, a potential anticancer resin from Garcinia hanburyi. Biomed Chromatogr 22: 637-644.
69. Liang CH, Shiu LY, Chang LC, Sheu HM, Kuo KW,. 2007. Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells. Mol Nutr Food Res 51: 999-1005.
70. Liang CH, Shiu LY, Chang LC, Sheu HM, Tsai EM, Kuo KW,. 2008. Solamargine enhances HER2 expression and increases the susceptibility of human lung cancer H661 and H69 cells to trastuzumab and epirubicin. Chem Res Toxicol 21: 393-399.
71. Liu HR, Peng XD, He HB, et al,. 2008. Antiproliferative activity of the total saponin of Solanum lyratum Thunb in HeLa cells by inducing apoptosis. Pharmazie 63: 836-842.
72. Liu WK, Ho JC, Qin G, Che CT,. 2002. Jolkinolide B induces neuroendocrine differentiation of human prostate LNCaP cancer cell line. Biochem Pharmacol 63: 951-957.
73. Lou YJ, Qian WB, Jin J,. 2007. Homoharringtonine induces apoptosis and growth arrest in human myeloma cells. Leuk Lymphoma 48: 1400-1406.
74. Lu DP, Qiu JY, Jiang B, et al,. 2002. Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report. Blood 99: 3136-3143.
75. Lu DP, Wang Q,. 2002. Current study of APL treatment in China. Int J Hematol 76 (Suppl 1): 316-318.
76. Lu J, Chew EH, Holmgren A,. 2007a. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci USA 104: 12288-12293.
77. Lu N, Yang Y, You QD, et al,. 2007b. Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1. Cancer Lett 258: 80-89.
78. Lu ZJ, Zhou Y, Song Q, et al,. 2010. Periplocin inhibits growth of lung cancer in vitro and in vivo by blocking AKT/ERK signaling pathways. Cell Physiol Biochem 26: 609-618.
79. Luo LY, Huang J, Gou BD, Zhang TL, Wang K,. 2006. Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by arsenic sulphide: involvement of serine/threonine protein phosphatases. Leuk Res 30: 1399-1405.
80. Ma G, Chong L, Li XC, Khan IA, Walker LA, Khan SI,. 2010. Selective inhibition of human leukemia cell growth and induction of cell cycle arrest and apoptosis by pseudolaric acid B. J Cancer Res Clin Oncol 136: 1333-1340.
81. 3) in the orthotopic metastasis model of androgen-independent prostate cancer. Cancer Res 61: 5432-5440.
82. Man S, Gao W, Zhang Y, et al,. 2011a. Formosanin C-inhibited pulmonary metastasis through repression of matrix metalloproteinases on mouse lung adenocarcinoma. Cancer Biol Ther 11: 592-598.
83. Man SL, Gao WY, Zhang YJ, Huang LQ, Liu CX,. 2011b. Paridis saponins inhibiting carcinoma growth and metastasis in vitro and in vivo. Arch Pharm Res 34: 43-50.
84. Man SL, Gao WY, Zhang YJ, Jin XH, Ma CY, Huang XX,. 2010. Separation and purification of effective constituents of Rhizoma Paridis saponins by serum pharmacochemistry guiding. Lat Am J Pharm 29: 1193-1198.
85. Man SL, Gao WY, Zhang YJ, et al,. 2009. Antitumor and antimetastatic activities of Rhizoma Paridis saponins. Steroids 74: 1051-1056.
86. Meng AG, Jiang LL,. 2009. Induction of G2/M arrest by pseudolaric acid B is mediated by activation of the ATM signaling pathway. Acta Pharmacol Sin 30: 442-450.
87. Meng H, Yang C, Jin J, Zhou Y, Qian W,. 2008. Homoharringtonine inhibits the AKT pathway and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Leuk Lymphoma 49: 1954-1962.
88. Meng Z, Yang P, Shen Y, et al,. 2009. Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer 115: 5309-5318.
89. Nakatomi K, Yoshikawa M, Oka M, et al,. 2001. Transport of 7-ethyl-10-hydroxycamptothecin (SN-38) by breast cancer resistance protein ABCG2 in human lung cancer cells. Biochem Biophys Res Commun 288: 827-832.
90. Newman DJ, Cragg GM,. 2007. Natural products as sources of new drugs over the last 25 years. J Nat Prod 70: 461-477.
91. Ni D, Ho DH, Vijjeswarapu M, Felix E, Rhea PR, Newman RA,. 2003. Metabolism of homoharringtonine, a cytotoxic component of the evergreen plant Cephalotaxus harringtonia. J Exp Ther Oncol 3: 47-52.
92. Nie F, Zhang X, Qi Q, et al,. 2009. Reactive oxygen species accumulation contributes to gambogic acid-induced apoptosis in human hepatoma SMMC-7721 cells. Toxicology 260: 60-67.
93. Ntalli NG, Cottiglia F, Bueno CA, et al,. 2010. Cytotoxic tirucallane triterpenoids from Melia azedarach fruits. Molecules 15: 5866-5877.
94. Oberlies NH, Kroll DJ, 2004. Camptothecin and Taxol: historic achievements in natural products research. J Nat Prod 67: 129-135.
95. Ohnishi S, Fukamiya N, Okano M, Tagahara K, Lee KH,. 1995. Bruceosides D, E, and F, three new cytotoxic quassinoid glucosides from Brucea javanica. J Nat Prod 58: 1032-1038.
96. Okouchi T, Abe T, Araki S, et al,. 2005. Mechanism of proliferation arrest of embryonic cells of Xenopus by diterpene compounds. Bioorg Med Chem 13: 3847-3851.
97. Ong RC, Lei J, Lee RK, et al,. 2008. Polyphyllin D induces mitochondrial fragmentation and acts directly on the mitochondria to induce apoptosis in drug-resistant HepG2 cells. Cancer Lett 261: 158-164.
98. Pandey MK, Sung B, Ahn KS, Kunnumakkara AB, Chaturvedi MM, Aggarwal BB,. 2007. Gambogic acid, a novel ligand for transferrin receptor, potentiates TNF-induced apoptosis through modulation of the nuclear factor-kappaB signaling pathway. Blood 110: 3517-3525.
99. Pantazis P, Han Z, Balan K, Wang Y, Wyche JH,. 2003. Camptothecin and 9-nitrocamptothecin (9NC) as anti-cancer, anti-HIV and cell-differentiation agents. Development of resistance, enhancement of 9NC-induced activities and combination treatments in cell and animal models. Anticancer Res 23: 3623-3638.
100. Park BY, Min BS, Ahn KS, et al,. 2007. Daphnane diterpene esters isolated from flower buds of Daphne genkwa induce apoptosis in human myelocytic HL-60 cells and suppress tumor growth in Lewis lung carcinoma (LLC)-inoculated mouse model. J Ethnopharmacol 111: 496-503.
101. Peng F, Wei YQ, Tian L, et al,. 2002. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand. J Cancer Res Clin Oncol 128: 223-230.
102. Ping YH, Lee HC, Lee JY, et al,. 2006. Anticancer effects of low-dose 10-hydroxycamptothecin in human colon cancer. Oncol Rep 15: 1273-1279.
103. Protiva P, Hopkins ME, Baggett S, et al,. 2008. Growth inhibition of colon cancer cells by polyisoprenylated benzophenones is associated with induction of the endoplasmic reticulum response. Int J Cancer 123: 687-694.
104. Qaddouri B, Guaadaoui A, Bellirou A, et al,. in press. The budding yeast 'Saccharomyces cerevisiae' as a drug discovery tool to identify plant-derived natural products with anti-proliferative properties. Evid Based Complement Alternat Med. DOI: 10.1093/ecam/nep069
105. Qiang L, Yang Y, You QD, et al,. 2008. Inhibition of glioblastoma cgrowth and angiogenesis by gambogic acid: an in vitro and in vivo study. Biochem Pharmacol 75: 1083-1092.
106. Qin Y, Meng L, Hu C, et al,. 2007. Gambogic acid inhibits the catalytic activity of human topoisomerase IIalpha by binding to its ATPase domain. Mol Cancer Ther 6: 2429-2440.
107. Qu GP, Xiu QY, Li B, Liu YA, Zhang LZ,. 2009. Arsenic trioxide inhibits the growth of human lung cancer cell lines via cell cycle arrest and induction of apoptosis at both normoxia and hypoxia. Toxicol Ind Health 25: 505-515.
108. Rauh R, Kahl S, Boechzelt H, Bauer R, Kaina B, Efferth T,. 2007. Molecular biology of cantharidin in cancer cells. Chin Med 2: 8.
109. Reutrakul V, Anantachoke N, Pohmakotr M, et al,. 2007. Cytotoxic and anti-HIV-1 caged xanthones from the resin and fruits of Garcinia hanburyi. Planta Med 73: 33-40.
110. Saad B, Azaizeh H, Abu-Hijleh G, Said O,. 2006. Safety of traditional arab herbal medicine. Evid Based Complement Alternat Med 3: 433-439.
111. Shi YL, Li MF,. 2007. Biological effects of toosendanin, a triterpenoid extracted from Chinese traditional medicine. Prog Neurobiol 82: 1-10.
112. Siu FM, Ma DL, Cheung YW, et al,. 2008. Proteomic and transcriptomic study on the action of a cytotoxic saponin (Polyphyllin D): induction of endoplasmic reticulum stress and mitochondria-mediated apoptotic pathways. Proteomics 8: 3105-3117.
113. Spera D, Siciliano T, De Tommasi N, Braca A, Vessieres A,. 2007. Antiproliferative cardenolides from Periploca graeca. Planta Med 73: 384-387.
114. Su CL, Lin TY, Lin CN, Won SJ,. 2009. Involvement of caspases and apoptosis-inducing factor in bufotalin-induced apoptosis of Hep 3B cells. J Agric Food Chem 57: 55-61.
115. Sun L, Zhao Y, Li X, Yuan H, Cheng A, Lou H,. 2010. A lysosomal-mitochondrial death pathway is induced by solamargine in human K562 leukemia cells. Toxicol In Vitro 24: 1504-1511.
116. Tada K, Takido M, Kitanaka S,. 1999. Limonoids from fruit of Melia toosendan and their cytotoxic activity. Phytochemistry 51: 787-791.
117. Takada Y, Kobayashi Y, Aggarwal BB,. 2005. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting I kappa B alpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 280: 17203-17212.
118. Takahashi K, Suzuki S, Hano Y, Nomura T,. 2002. Protein kinase C activation by iridal type triterpenoids. Biol Pharm Bull 25: 432-436.
119. Tan WF, Zhang XW, Li MH, et al,. 2004. Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect. Eur J Pharmacol 499: 219-228.
120. Tanaka T, Kohno H, Shimada R, et al,. 2000. Prevention of colonic aberrant crypt foci by dietary feeding of garcinol in male F344 rats. Carcinogenesis 21: 1183-1189.
121. Tang MZ, Wang ZF, Shi YL,. 2004. Involvement of cytochrome c release and caspase activation in toosendanin-induced PC12 cell apoptosis. Toxicology 201: 31-38.
122. Tang XD, Zhou X, Zhou KY,. 2009. Dauricine inhibits insulin-like growth factor-I-induced hypoxia inducible factor 1alpha protein accumulation and vascular endothelial growth factor expression in human breast cancer cells. Acta Pharmacol Sin 30: 605-616.
123. Tao SJ, Guan SH, Wang W, et al,. 2009. Cytotoxic polyprenylated xanthones from the resin of Garcinia hanburyi. J Nat Prod 72: 117-124.
124. Tong H, Ren Y, Zhang F, Jin J,. 2008. Homoharringtonine affects the JAK2-STAT5 signal pathway through alteration of protein tyrosine kinase phosphorylation in acute myeloid leukemia cells. Eur J Haematol 81: 259-266.
125. Tong YG, Zhang XW, Geng MY, et al,. 2006. Pseudolarix acid B, a new tubulin-binding agent, inhibits angiogenesis by interacting with a novel binding site on tubulin. Mol Pharmacol 69: 1226-1233.
126. Vayssade M, Faridoni-Laurens L, Benard J, Ahomadegbe JC,. 2002. Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatment. Biochem Pharmacol 63: 1609-1617.
127. Wang CC, Wu CH, Hsieh KJ, Yen KY, Yang LL,. 2000. Cytotoxic effects of cantharidin on the growth of normal and carcinoma cells. Toxicology 147: 77-87.
128. Wang HB, Chu WJ, Wang Y, et al,. 2010. Diterpenoids from the roots of Euphorbia fischeriana. J Asian Nat Prod Res 12: 1038-1043.
129. Wang LL, Li ZL, Song DD, et al,. 2008a. Two novel triterpenoids with antiproliferative and apoptotic activities in human leukemia cells isolated from the resin of Garcinia hanburyi. Planta Med 74: 1735-1740.
130. Wang LW, Shi YL, Wang N, et al,. 2009a. Association of oxidative stress with realgar-induced differentiation in human leukemia HL-60 cells. Chemotherapy 55: 460-467.
131. Wang LY, Unehara T, Kitanaka S,. 2005. Anti-inflammatory activity of new guaiane type sesquiterpene from Wikstroemia indica. Chem Pharm Bull(Tokyo) 53: 137-139.
132. Wang LY, Wang NL, Yao XS, Miyata S, Kitanaka S,. 2003. Euphane and tirucallane triterpenes from the roots of Euphorbia kansui and their in vitro effects on the cell division of Xenopus. J Nat Prod 66: 630-633.
133. Wang MC, Liu SX, Liu PB,. 2006. Gene expression profile of multiple myeloma cell line treated by realgar. J Exp Clin Cancer Res 25: 243-249.
134. Wang N, Wang LW, Gou BD, Zhang TL, Wang K,. 2008b. Realgar-induced differentiation is associated with MAPK pathways in HL-60 cells. Cell Biol Int 32: 1497-1505.
135. Wang X, Chen Y, Han QB, et al,. 2009b. Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma. Proteomics 9: 242-253.
136. Wang Y, Ma X, Yan S, et al,. 2009c. 17-Hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells. Cancer Res 69: 7302-7310.
137. Wang ZY,. 2001. Arsenic compounds as anticancer agents. Cancer Chemother Pharmacol 48 (Suppl 1): S72-S76.
138. Wong VK, Chiu P, Chung SS, et al,. 2005. Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo. Clin Cancer Res 11: 6002-6011.
139. Wu JZ, Ho PC,. 2006. Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding. Eur J Pharm Sci 29: 35-44.
140. Wu R, Chaung WW, Zhou M, et al,. 2010. Milk fat globule EGF factor 8 attenuates sepsis-induced apoptosis and organ injury in alcohol-intoxicated rats. Alcohol Clin Exp Res 34: 1625-1633.
141. Xie H, Qin YX, Zhou YL, et al,. 2009. GA3, a new gambogic acid derivative, exhibits potent antitumor activities in vitro via apoptosis-involved mechanisms. Acta Pharmacol Sin 30: 346-354.
142. Xu H, Lv M, Tian X,. 2009. A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007. Curr Med Chem 16: 327-349.
143. Yan LL, Zhang YJ, Gao WY, Man SL, Wang Y,. 2009. In vitro and in vivo anticancer activity of steroid saponins of Paris polyphylla var. yunnanensis. Exp Oncol 31: 27-32.
144. Yang H, Chen D, Cui QC, Yuan X, Dou QP,. 2006. Celastrol, a triterpene extracted from the Chinese 'Thunder of God Vine', is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. Cancer Res 66: 4758-4765.
145. Yang S, Chen J, Guo Z, et al,. 2003. Triptolide inhibits the growth and metastasis of solid tumors. Mol Cancer Ther 2: 65-72.
146. Yang Y, Yang L, You QD, et al,. 2007. Differential apoptotic induction of gambogic acid, a novel anticancer natural product, on hepatoma cells and normal hepatocytes. Cancer Lett 256: 259-266.
147. Yang YX, Sun XF, Cheng AL, et al,. 2009a. Increased expression of HSP27 linked to vincristine resistance in human gastric cancer cell line. J Cancer Res Clin Oncol 135: 181-189.
148. Yang Z, Li C, Wang X, et al,. 2010. Dauricine induces apoptosis, inhibits proliferation and invasion through inhibiting NF-kappaB signaling pathway in colon cancer cells. J Cell Physiol 225: 266-275.
149. Yang Z, Wong EL, Shum TY, Che CM, Hui Y,. 2005. Fluorophore-appended steroidal saponin (dioscin and polyphyllin D) derivatives. Org Lett 7: 669-672.
150. Yang ZG, Chen AQ, Liu B,. 2009b. Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205). Chem Biodivers 6: 924-933.
151. Yasukawa K, Akihisa T, Yoshida ZY, Takido M,. 2000. Inhibitory effect of euphol, a triterpene alcohol from the roots of Euphorbia kansui, on tumour promotion by 12-O-tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. J Pharm Pharmacol 52: 119-124.
152. Yeh YC, Liu TJ, Wang LC, et al,. 2009. A standardized extract of Ginkgo biloba suppresses doxorubicin-induced oxidative stress and p53-mediated mitochondrial apoptosis in rat testes. Br J Pharmacol 156: 48-61.
153. Yi T, Yi Z, Cho SG, et al,. 2008. Gambogic acid inhibits angiogenesis and prostate tumor growth by suppressing vascular endothelial growth factor receptor 2 signaling. Cancer Res 68: 1843-1850.
154. Yin HX, Xue D, Wu M, Chen Y, Chen C, Zhang H,. 2007. Quality estimation on material medica of Rhizoma Paridis from Sichuan & Yunnan province. Zhong Yao Cai 30: 771-774.
155. Yin T, Wu YL, Sun HP, et al,. 2004. Combined effects of As4S4 and imatinib on chronic myeloid leukemia cells and BCR-ABL oncoprotein. Blood 104: 4219-4225.
156. Yoo WS, Kim J, Lee YW, Yoon DH, Cho CK, Yoo HS,. 2009. Toxicity studies on Secretio Bufonis: a traditional supplement in Asia. J Acupunct Meridian Stud 2: 159-164.
157. Yoshida C, Hishiyama K, Miyazaki K, et al,. 2010. Analysis of inhibition of topoisomerase IIalpha and cancer cell proliferation by ingenolEZ. Cancer Sci 101: 374-378.
158. Yoshida K, Tanaka T, Hirose Y, et al,. 2005. Dietary garcinol inhibits 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats. Cancer Lett 221: 29-39.
159. Yoshida M, Feng W, Saijo N, Ikekawa T,. 1996. Antitumor activity of daphnane-type diterpene gnidimacrin isolated from Stellera chamaejasme L. Int J Cancer 66: 268-273.
160. Yoshida M, Yokokura H, Hidaka H, Ikekawa T, Saijo N,. 1998. Mechanism of antitumor action of PKC activator, gnidimacrin. Int J Cancer 77: 243-250.
161. Youn UJ, Chen QC, Jin WJ, et al,. 2007. Cytotoxic lignans from the stem bark of Magnolia officinalis. J Nat Prod 70: 1687-1689.
162. Yu J, Guo QL, You QD, et al,. 2007. Gambogic acid-induced G2/M phase cell-cycle arrest via disturbing CDK7-mediated phosphorylation of CDC2/p34 in human gastric carcinoma BGC-823 cells. Carcinogenesis 28: 632-638.
163. Yu JH, Wang HJ, Li XR, Tashiro S, Onodera S, Ikejima T,. 2008. Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells. Acta Pharmacol Sin 29: 1069-1076.
164. Yurkovetskiy AV, Fram RJ,. 2009. XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer. Adv Drug Deliv Rev 61: 1193-1202.
165. Zhan ZJ, Fan CQ, Ding J, Yue JM,. 2005. Novel diterpenoids with potent inhibitory activity against endothelium cell HMEC and cytotoxic activities from a well-known TCM plant Daphne genkwa. Bioorg Med Chem 13: 645-655.
166. Zhang B, Wang ZF, Tang MZ, Shi YL,. 2005. Growth inhibition and apoptosis-induced effect on human cancer cells of toosendanin, a triterpenoid derivative from Chinese traditional medicine. Invest New Drugs 23: 547-553.
167. Zhang HZ, Kasibhatla S, Wang Y, et al,. 2004a. Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay. Bioorg Med Chem 12: 309-317.
168. Zhang S, Li X, Zhang F, Yang P, Gao X, Song Q,. 2006. Preparation of yuanhuacine and relative daphne diterpene esters from Daphne genkwa and structure-activity relationship of potent inhibitory activity against DNA topoisomerase I. Bioorg Med Chem 14: 3888-3895.
169. Zhang X, Xiao HB, Xue XY, Sun YG, Liang XM,. 2007. Simultaneous characterization of isoflavonoids and astragalosides in two Astragalus species by high-performance liquid chromatography coupled with atmospheric pressure chemical ionization tandem mass spectrometry. J Sep Sci 30: 2059-2069.
170. Zhang XW, Qing C, Xu B,. 1999. Apoptosis induction and cell cycle perturbation in human hepatoma hep G2 cells by 10-hydroxycamptothecin. Anticancer Drugs 10: 569-576.
171. Zhang Y, Wu LJ, Tashiro S, Onodera S, Ikejima T,. 2003. Intracellular regulation of evodiamine-induced A375-S2 cell death. Biol Pharm Bull 26: 1543-1547.
172. Zhang Y, Zhang QH, Wu LJ, Tashiro S, Onodera S, Ikejima T,. 2004b. Atypical apoptosis in L929 cells induced by evodiamine isolated from Evodia rutaecarpa. J Asian Nat Prod Res 6: 19-27.
173. Zhao J, Qi Q, Yang Y, et al,. 2008. Inhibition of alpha(4) integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with gambogic acid. Eur J Pharmacol 589: 127-131.
174. Zhao L, Shan B, Du Y, Wang M, Liu L, Ren FZ,. 2010. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling. Oncol Rep 24: 375-383.
175. Zhao W, Lu X, Yuan Y, et al,. 2011. Effect of size and processing method on the cytotoxicity of realgar nanoparticles in cancer cell lines. Int J Nanomedicine 6: 1569-1577.
176. Zhao Y, Kang LP, Liu YX, et al,. 2007. Three new steroidal saponins from the rhizome of Paris polyphylla. Magn Reson Chem 45: 739-744.
177. Zhong L, Chen F, Han J, Shao N, Ouyang R,. 2003. Effects of red orpiment on cell morphology and expression of PML mRNA and protein in NB4 and HL-60 cells. Chin Med J (Engl) 116: 148-150.